$MRNAIn the daily chart I can see the falling wedge is ready to brake out. 1 hour chart I like the accumulation in the last 2 months. brake out is expected. the target is 49 if you see momentum.
as long as the price stay above 24.70.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−8.72 USD
−3.56 B USD
3.24 B USD
342.49 M
About Moderna, Inc.
Sector
Industry
CEO
Stéphane Bancel
Website
Headquarters
Cambridge
Founded
2010
FIGI
BBG003PHHZT1
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.
Related stocks
MRNA: The Wager No One Wants to Talk AboutModerna (MRNA) has become a pariah in many portfolios. Between reputational overhangs, political weaponization of its COVID success, and fresh regulatory pressures like the labeling requirement just triggered by Florida, the company has seemingly absorbed wave after wave of bad press.
But that’s th
$MRNA – Long-Term Setup Brewing | Major Move Incoming?Moderna ( NASDAQ:MRNA ) may be gearing up for a multi-month reversal after a prolonged downtrend. Price action is compressing in a tight base, suggesting a potential 6+ month breakout could be in the cards.
📊 Key Technical Notes:
Trading near long-term support with signs of accumulation
Bullish d
Bullish wedge coiling up; bird flu incoming ?
1. Over the past year moderna is down 85% and from its pandemic highs, down 90%+ so simply that alone tells you the stock is quite cheap and beaten down. It is currently trading at 2020 levels as if a world changing pandemic never happened.
2. Moderna is currently trading around its book value o
MODERNA $305 | Bidding at $220 and $150 Informed Players and speculators at Sub $100 levels are booking gains
we wait for additional drwadowns and re accomodation ACCUMULATION of designated Bankers for the next run up OR cycle
Vaccine COViD was intense HiV was the sell on News..
we await next Drama and Biden Policy on Healthcare etc..
A Long-term Bullish Trend ?With an upcoming Earnings report we can observe rather uncertain future behavior.
But since the trend has been bearish for a longer period of time and the price is "nearly" at the same position which was achieved for the first time in early April in 2019, we can, mostly based only on the technical
MRNA close to buyI think 20$ is a good support to buy MRNA. It gave 100% of the covid gains back.
Base - Rally - Base pattern
Moderna (MRNA) Shares Plunge Nearly 9%Moderna (MRNA) Shares Plunge Nearly 9%
Moderna (MRNA) shares tumbled by approximately 8.9%, falling below $29—marking their lowest level since April 2020, when global markets were shaken by the COVID-19 pandemic.
Since the start of 2025, MRNA’s share price has declined by around 32%.
Why Did MR
Moderna. Why Anti-Covid19 Juggernaut Goes 'The Bloodmachine'It's gone 5 years or so... (Duh..? 5 years, really? 🥴) since everyone was talking about COVID-19 pandemic, vaccines, "world will never be the same again", and so on.
- And now?..
- It's gone. It's absolutely gone..! Since nothing last forever and no one should chase a feather, or dust in the wind.
$MRNA: Moderna – mRNA Magic or Biotech Bubble?(1/9)
Good afternoon, folks! ☀️ NASDAQ:MRNA : Moderna – mRNA Magic or Biotech Bubble?
CEO drops $5M on shares, sparking a 9% surge—is this a biotech rocket or a hot air balloon ready to pop? Let’s crack the code! 🔍
(2/9) – PRICE PERFORMANCE 📊
• Current Trend: Up 9% after CEO’s $5M buy on Mar 5,
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where MRNA is featured.
Frequently Asked Questions
The current price of MRNA is 25.90 USD — it has increased by 1.97% in the past 24 hours. Watch Moderna, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Moderna, Inc. stocks are traded under the ticker MRNA.
MRNA stock has fallen by −2.52% compared to the previous week, the month change is a −7.17% fall, over the last year Moderna, Inc. has showed a −80.46% decrease.
We've gathered analysts' opinions on Moderna, Inc. future price: according to them, MRNA price has a max estimate of 198.00 USD and a min estimate of 20.00 USD. Watch MRNA chart and read a more detailed Moderna, Inc. stock forecast: see what analysts think of Moderna, Inc. and suggest that you do with its stocks.
MRNA reached its all-time high on Aug 10, 2021 with the price of 497.49 USD, and its all-time low was 11.54 USD and was reached on Aug 7, 2019. View more price dynamics on MRNA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MRNA stock is 2.42% volatile and has beta coefficient of 0.95. Track Moderna, Inc. stock price on the chart and check out the list of the most volatile stocks — is Moderna, Inc. there?
Today Moderna, Inc. has the market capitalization of 10.02 B, it has decreased by −7.13% over the last week.
Yes, you can track Moderna, Inc. financials in yearly and quarterly reports right on TradingView.
Moderna, Inc. is going to release the next earnings report on Jul 31, 2025. Keep track of upcoming events with our Earnings Calendar.
MRNA earnings for the last quarter are −2.52 USD per share, whereas the estimation was −3.12 USD resulting in a 19.13% surprise. The estimated earnings for the next quarter are −2.96 USD per share. See more details about Moderna, Inc. earnings.
Moderna, Inc. revenue for the last quarter amounts to 108.00 M USD, despite the estimated figure of 106.18 M USD. In the next quarter, revenue is expected to reach 116.35 M USD.
MRNA net income for the last quarter is −971.00 M USD, while the quarter before that showed −1.12 B USD of net income which accounts for 13.30% change. Track more Moderna, Inc. financial stats to get the full picture.
No, MRNA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 21, 2025, the company has 5.8 K employees. See our rating of the largest employees — is Moderna, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Moderna, Inc. EBITDA is −3.54 B USD, and current EBITDA margin is −116.07%. See more stats in Moderna, Inc. financial statements.
Like other stocks, MRNA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Moderna, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Moderna, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Moderna, Inc. stock shows the sell signal. See more of Moderna, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.